Sarms
AC-262536 (Accadrine)
AC-262536 is a non-steroidal selective androgen receptor modulator (SARM) designed to promote
muscle growth with fewer side effects than traditional anabolic steroids.
ACP-105
ACP-105 is an investigational non-steroidal SARM (Selective Androgen Receptor Modulator)
developed to provide the muscle and bone-building benefits of anabolic steroids while minimizing
androgenic side effects.
BMS-564929
BMS-564929 is a potent, highly selective androgen receptor modulator developed by Bristol-Myers
Squibb for the treatment of age-related muscle loss (sarcopenia) and androgen deficiency.
GL-200-031
GL-200-031 is an investigational selective androgen receptor modulator (SARM) developed for muscle
wasting, osteoporosis, and age-related functional decline research.
GSK-2881078
GSK-2881078 is a highly selective, next-generation SARM developed by GlaxoSmithKline for research
in treating sarcopenia (age-related muscle loss) and osteoporosis.
KBL-757
KBL-757 is an investigational selective androgen receptor modulator (SARM) designed to promote
muscle and bone growth with minimal side effects on reproductive tissues.
LGD-3303
LGD-3303 is a second-generation SARM developed for muscle wasting, osteoporosis, and frailty
syndrome research. It is chemically related to Ligandrol (LGD-4033) but designed with enhanced
anabolic potency and improved oral bioavailability.
Ligandrol (LGD-4033)
Ligandrol (LGD-4033) is one of the most studied SARMs (Selective Androgen Receptor Modulators),
originally developed to combat muscle wasting, osteoporosis, and age-related frailty.
MK-2866 (Ostarine / Enobosarm)
MK-2866, also known as Ostarine or Enobosarm, is the most clinically studied SARM to date. Originally
developed for muscle wasting, osteoporosis, and cancer-related cachexia, it is known for its mild
anabolic effects and low side effect profile.
PF-06260414
PF-06260414 is an investigational selective androgen receptor modulator (SARM) developed by Pfizer
for the treatment of muscle wasting, sarcopenia, and osteoporosis.
RAD-140 (Testolone)
RAD-140, commonly known as Testolone, is a potent selective androgen receptor modulator (SARM)
developed for muscle wasting, osteoporosis, and neurodegenerative disease research.
RAD-150 (Esterified RAD-140)
RAD-150, also known as TLB-150 Benzoate, is a chemically esterified version of RAD-140
(Testolone). This modification was designed to extend the compound’s half-life, improve stability in the
bloodstream, and deliver slower, more sustained anabolic effects.
Andarine (S-4)
Andarine (S-4) is one of the first-generation SARMs, originally developed to treat muscle wasting,
osteoporosis, and benign prostatic hyperplasia (BPH).
S4-Myostatin (Modified S-4)
S4-Myostatin is an unverified research compound claimed to combine the muscle-preserving effects of
Andarine (S-4) with myostatin-inhibiting properties.
S-23
S-23 is one of the most potent SARMs developed to date, originally researched for male hormonal
contraception and muscle-wasting disorders.